WebJan 1, 2024 · Suzhou SyMap Medical raised nearly $100 million in an E Round financing to conduct clinical trials of its renal denervation devices (see story). The company also announced a strategic collaboration with Israel 's Pythagoras Medical that allows SyMap full rights to use all of Pythagoras' assets including its ConfidenHT™ Renal Nerve Mapping … WebFeb 23, 2024 · SUZHOU, China, Feb. 23, 2024 /PRNewswire/ -- SyMap Medical Ltd. (Suzhou, China) announced successful completion of enrollment in the company's SMART Study …
SyMap Medical - Funding, Financials, Valuation & Investors
WebIntroduction. SymMap integrates traditional Chinese medicine (TCM) with modern medicine (MM) through both internal molecular mechanism and external symptom mapping, thus … WebDec 7, 2024 · December 7, 2024—SyMap Medical announced the closing of a financing round of approximately $100 million. SyMap is a China-based company focused on … nazareth to bethlehem miles
SyMap Medical Ltd. Closes Largest Financing Round in Renal
WebAug 31, 2024 · Abstract: A device for mapping and ablating the renal nerves distributed on the renal artery is provided, said device comprising a guide catheter (11), a mapping … WebDec 29, 2024 · SUZHOU, China, Dec. 29, 2024 /PRNewswire/ -- SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical. With this win-win … WebMay 4, 2016 · SyMap Medical (Suzhou), Ltd. ClinicalTrials.gov Identifier: NCT02761811 Other Study ID Numbers: 2015-01 : First Posted: May 4, 2016 Key Record Dates: Last … mark wiggins foot doctor vidalia ga